Добірка наукової літератури з теми "Anxiety treatments"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Anxiety treatments".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Anxiety treatments":

1

Pollack, Mark H. "Pharmacologic Treatments for Anxiety." CNS Spectrums 9, no. 4 (2004): 4–8. http://dx.doi.org/10.1017/s1092852900027103.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
While the public health perspective prioritizes large populations of affected individuals, our job as clinicians is to help one patient at a time. Over the last 10–20 years, there has been marked improvement in pharmacologic and psychosocial interventions available for patients with anxiety disorders (Slide 8).The use of antidepressants, particularly the serotonergic and serotonergic noradrenergic agents, have received increased attention as first-line treatment for most of the anxiety disorders, including panic disorder, social phobia, posttraumatic stress disorder (PTSD), and generalized anxiety disorder (GAD). Antidepressants are often used as first-line therapy for anxiety disorders because of their broad spectrum of efficacy against common comorbidities, especially depression, and because of concern about benzodiazepine-associated dependence, abuse liability, and lack of efficacy for depression and other comorbidities (Slide 9).These newer antidepressants have advantages over the older antidepressants, particularly the tricyclics and the monoamine oxidase inhibitors, in that they are generally better tolerated and more appropriate for use in potentially suicidal patients because they are less lethal in overdose. However, there are some side effects that may limit their use in some patients. In the case of the serotonergic antidepressants, many patients are hesitant to initiate or maintain treatment due to concerns about sexual dysfunction.
2

Struzik, Lukasz, Monica Vermani, Aimee Coonerty-Femiano, and Martin A. Katzman. "Treatments for generalized anxiety disorder." Expert Review of Neurotherapeutics 4, no. 2 (March 2004): 285–94. http://dx.doi.org/10.1586/14737175.4.2.285.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Nickell, P. V. "Panic Anxiety and Its Treatments." Psychiatric Services 46, no. 2 (February 1995): 190. http://dx.doi.org/10.1176/ps.46.2.190.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Szuhany, Kristin L., and Naomi M. Simon. "Anxiety Disorders." JAMA 328, no. 24 (December 27, 2022): 2431. http://dx.doi.org/10.1001/jama.2022.22744.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
ImportanceAnxiety disorders have a lifetime prevalence of approximately 34% in the US, are often chronic, and significantly impair quality of life and functioning.ObservationsAnxiety disorders are characterized by symptoms that include worry, social and performance fears, unexpected and/or triggered panic attacks, anticipatory anxiety, and avoidance behaviors. Generalized anxiety disorder (6.2% lifetime prevalence), social anxiety disorder (13% lifetime prevalence), and panic disorder (5.2% lifetime prevalence) with or without agoraphobia are common anxiety disorders seen in primary care. Anxiety disorders are associated with physical symptoms, such as palpitations, shortness of breath, and dizziness. Brief screening measures applied in primary care, such as the Generalized Anxiety Disorder–7, can aid in diagnosis of anxiety disorders (sensitivity, 57.6% to 93.9%; specificity, 61% to 97%). Providing information about symptoms, diagnosis, and evidence-based treatments is a first step in helping patients with anxiety. First-line treatments include pharmacotherapy and psychotherapy. Selective serotonin reuptake inhibitors (SSRIs, eg, sertraline) and serotonin-norepinephrine reuptake inhibitors (SNRIs, eg, venlafaxine extended release) remain first-line pharmacotherapy for generalized anxiety disorder, social anxiety disorder, and panic disorder. Meta-analyses suggest that SSRIs and SNRIs are associated with small to medium effect sizes compared with placebo (eg, generalized anxiety disorder: standardized mean difference [SMD], −0.55 [95% CI, −0.64 to −0.46]; social anxiety disorder: SMD, −0.67 [95% CI, −0.76 to −0.58]; panic disorder: SMD, −0.30 [95% CI, −0.37 to −0.23]). Cognitive behavioral therapy is the psychotherapy with the most evidence of efficacy for anxiety disorders compared with psychological or pill placebo (eg, generalized anxiety disorder: Hedges g = 1.01 [large effect size] [95% CI, 0.44 to 1.57]; social anxiety disorder: Hedges g = 0.41 [small to medium effect] [95% CI, 0.25 to 0.57]; panic disorder: Hedges g = 0.39 [small to medium effect[ [95% CI, 0.12 to 0.65]), including in primary care. When selecting treatment, clinicians should consider patient preference, current and prior treatments, medical and psychiatric comorbid illnesses, age, sex, and reproductive planning, as well as cost and access to care.Conclusions and RelevanceAnxiety disorders affect approximately 34% of adults during their lifetime in the US and are associated with significant distress and impairment. First-line treatments for anxiety disorders include cognitive behavioral therapy, SSRIs such as sertraline, and SNRIs such as venlafaxine extended release.
5

Lader, M. H., and A. J. Bond. "Interaction of pharmacological and psychological treatments of anxiety." British Journal of Psychiatry 173, S34 (July 1998): 42–48. http://dx.doi.org/10.1192/s0007125000293513.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background Pharmacological and psychological treatments for anxiety are often combined in clinical practice but there is little research from which to predict the effects.Method The theoretical outcomes of combining treatments and methods of investigating these as well as methodological difficulties are described. Studies which have been completed in anxiety disorders are reviewed. A double-blind trial, using a factorial design, evaluated buspirone v. placebo and anxiety management training v. nondirective therapy in 60 patients with generalised anxiety disorder (GAD).Results Relatively few germane studies have been carried out in the anxiety disorders except for panic disorder with agoraphobia. There is some evidence that short-term, combined treatment does confer additional benefits which are evident both in speed of onset and lasting remission. All four treatment combinations proved effective in the short-term treatment of GAD.Conclusions More studies examining combined treatment are needed. Although differences may not be apparent at the end of the treatment period, psychological treatment appears to confer advantages at follow-up.
6

Abdul Khaiyom, Jamilah Hanum, Firdaus Mukhtar, and Oei Tian Po. "Treatments for Anxiety Disorders in Malaysia." Malaysian Journal of Medical Sciences 26, no. 3 (2019): 24–36. http://dx.doi.org/10.21315/mjms2019.26.3.2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Antony, Martin M. "Enhancing Current Treatments for Anxiety Disorders." Clinical Psychology: Science and Practice 9, no. 1 (May 11, 2006): 91–94. http://dx.doi.org/10.1093/clipsy.9.1.91.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Shaywitz, Jonathan. "Medication Treatments for Social Anxiety Disorder." FOCUS 9, no. 3 (January 2011): 273–77. http://dx.doi.org/10.1176/foc.9.3.foc273.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

De Silva, P. "Long-term treatments of anxiety disorders." Behaviour Research and Therapy 35, no. 11 (November 1997): 1055. http://dx.doi.org/10.1016/s0005-7967(97)88441-0.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Zhou, Qi, Nan Yang, Kehu Yang, Janne Estill, and Yaolong Chen. "Pharmacological treatments for generalised anxiety disorder." Lancet 394, no. 10205 (October 2019): 1229. http://dx.doi.org/10.1016/s0140-6736(19)31409-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Дисертації з теми "Anxiety treatments":

1

Stratford, Hannah Joy. "Anxiety and bipolar spectrum disorders : psychological treatments and mental imagery." Thesis, University of Oxford, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.599903.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Anxiety is a clinically significant feature of bipolar spectrum disorders [BP]. The. rate of anxiety symptoms and/or comorbid anxiety diagnoses is high, and it contributes to worse outcomes in a range of domains. There is an accumulation of evidence that psychological therapy is effective for anxiety, which is not so for BP. Mental imagery is implicated in the maintenance of anxiety and is a promising avenue of research in BP. A cognitive model of bipolar disorder posits that imagery is an emotional amplifier in mania and anxiety. Paper A presents a systematic review of the literature of psychological therapies for anxiety in BP. Twenty-two studies were identified, though no formal synthesis was possible. Preliminary data for CBT for obsessive compulsive disorder, generalised anxiety disorder, and post-traumatic stress disorder in a BP population are promising, and further research is warranted. Furthermore, the addition of an anxiety module to CBT for BP effectively reduces anxiety, and may have additional benefits in other domains. Pilot research applying other evidence-based CBT treatments for comorbid anxiety is indicated, as are RCTs for CBT for cyclothymia and rapid cycling BP. The addition of an anxiety module may Improve the effectiveness of psychological therapy for BP, further review and research is necessary to explore this. Paper B presents an empirical study, com paring imagery processes in adults with BP (currently euthymic), mixed anxiety disorders, and non-clinical controls. Genera imagery use, intrusive and deliberate prospective imagery, and characteristics of image ' during different mood states are explored. People with anxiety have high levels 0 general imagery use and intrusive prospective imagery. Unlike the clinical groups, the control group appears to have a bias against negative imagery in a deliberate prospective imagery task. Retrospective report of mental imagery during past low, anxious and high mood states gives partial support to the imagery as an emotional amplifier theory, and similarities between the clinical groups may illuminate the high rates of comorbidity. Future research is discussed.
2

Kagan, Elana Rachel. "Targeting Parental Accommodation in the Treatment of Youth with Anxiety: A Comparison of Two Cognitive Behavioral Treatments." Diss., Temple University Libraries, 2019. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/590292.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Psychology
Ph.D.
Parental accommodation refers to the ways in which a parent modifies his/her behavior to avoid or reduce the distress their child experiences. Parental accommodation of youth anxiety is common, and reduction in accommodation is associated with reduced anxiety after treatment. The current study evaluated the efficacy of an adapted cognitive-behavioral therapy program (CBT) designed to address parental accommodation (Accommodation Reduction Intervention; ARI). Sixty children and adolescents (age 7-17) and their parents were evaluated for youth anxiety and parental accommodation before and after 16 weeks of treatment. Thirty youth received ARI and 30 received Coping Cat (CC). Both youth anxiety and parental accommodation were significantly reduced from pre to posttreatment in youth who received ARI as well as those who received CC. No significant difference was found between the two treatment conditions on any measure of anxiety or accommodation. Findings indicate that an adapted CBT that focuses on parent accommodation (ARI) produced favorable outcomes comparable to Coping Cat. Clinical implications and future directions are discussed.
Temple University--Theses
3

Linda, Nondumiso Innocentia. "Investigating the practices in the management of anxiety disorders by Zulu traditional healers." Thesis, University of Zululand, 2017. http://hdl.handle.net/10530/1582.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
A dissertation submitted to the Faculty of Arts in partial fulfilment of the requirements for the Degree of Master of Arts (Clinical Psychology) in the Department of Psychology at the University of Zululand, 2017
The aim and objectives of the study were to investigate the management of anxiety disorders by Zulu traditional healers. Here the term management refers not exclusively to treatment but rather encompasses conceptualisation and causes of anxiety, symptom presentation and diagnostic procedures, treatment methods, and referral of patients with anxiety. The study was conducted at KwaDlangezwa and Esikhawini areas in Zululand, South Africa. A qualitative approach was adopted for the study. A snowball sampling technique was used to collect the sample. The inclusion criterion was diviners who are currently in practice. The sample comprised of 14 diviners. Semi-structured interviews were used in the collection of data. The interviews were audio-recorded and transcribed verbatim. The data was analysed and interpreted using thematic content analysis. Within the study the concept of anxiety was understood in relation to the causes. Anxiety was discussed under the headings of functional and pathological anxiety. The diviners diagnose and treat exclusively pathological anxiety. Pathological anxiety was said to be caused by either witchcraft or ancestral calling. In the category of pathological anxiety three types of anxiety were described, and they were inyoni (affecting mostly children), uvalo lwezilwane (anxiety through bewitchment and uvalo lwedlozi (related to ancestral calling). The diviners indicated that anxiety is not a mental disorder but rather a physical illness. Although the treatment methods varied amongst the diviners, they were all indicated to be effective. If a patient was not responsive to treatment, the patient would be referred to other healers first and then a referral to clinics or/ and hospitals would be made. However, if there was an underlying medical condition, patients would be referred immediately to clinics and/or hospitals.
4

Young, Jennica Marie. "THE ATTENUATING EFFECTS OF A COMBINATIONAL TREATMENT AFTER EXPERIMENTAL TBI ON PROPERTIES OF ANXIETY." OpenSIUC, 2019. https://opensiuc.lib.siu.edu/dissertations/1688.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The purpose of this study is to investigate an animal model of distress (conditioned suppression) to assess the effects of magnesium (MAG) and nicotinamide (B3) administration on recovery of anxiety-like behavior following traumatic brain injury (TBI). Post-traumatic stress disorder (PTSD) is comorbid with TBI and both affects a victim’s ability to maintain daily activities and have a good quality of life. Administration of MAG decreases swelling of the brain considerably and lessens cell death. B3 is a neuroprotective precursor to NAD+ and enhances energy levels as well has help reduce free radicals after TBI. A conditioned suppression procedure is an established method for generating disruptive fearful anxiety-like responses in animals and these treatments may help to reduce anxiety responses.
5

Wong, Judy. "Concurrent Treatments of Substance Use Disorders with Anxiety or Trauma: A Comprehensive Meta-Analysis." Diss., Temple University Libraries, 2014. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/294389.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Psychology
Ph.D.
Among those seeking treatment for a substance use disorder (SUD), the prevalence of a concurrent anxiety disorder or posttraumatic stress disorder (PTSD) is surprisingly high, with some estimates placing the comorbidity rate at 33% to 43%. There is evidence that this comorbidity is associated with greater symptom severity, impairment, and substance use relapse than when the disorders present independently. One of the greatest challenges that clinicians face when presented with a patient with an anxiety disorder/PTSD and SUD is deciding how to approach treatment. Though the prevailing approach has been to treat the disorders sequentially, with the SUD receiving initial attention, there is a movement towards developing integrated or concurrent treatment models. The current meta-analytic study examined integrated or concurrent psychotherapies or pharmacotherapies for SUDs and anxiety disorders or PTSD. A meta-analysis on this topic is particularly important given the generally mixed findings of existing randomized controlled trials in this area of research. Our main question of interest was how integrated/concurrent treatments compared to single-target treatments. In addition, we explored whether there were outcome differences between psychotherapy and pharmacotherapy, between anxiety disorders and PTSD, and differences based on treatment setting (e.g., substance use treatment center versus other settings). Our findings suggested that integrated or concurrent treatments were superior in reducing anxiety or PTSD symptoms, compared to treatments that only targeted substance use or anxiety/PTSD. The effect, however, was small. There was no evidence that integrated or concurrent treatments improved substance use outcomes in comparison to stand alone substance use treatment. We also found evidence that treatment studies conducted at substance use inpatient or outpatient programs produced smaller anxiety/PTSD effects. A trend was found suggesting combined psychotherapy-pharmacotherapy interventions may be more effective than psychotherapy alone. No difference was found between treatments targeting PTSD versus anxiety disorders. Implications of our findings are discussed.
Temple University--Theses
6

Dahan, Jessica. "Individual Child Cognitive Behavioral Treatment versus Child-Parent Cognitive Behavioral Treatments for Anxiety Disorders in Children and Adolescents: Comparative Outcomes." FIU Digital Commons, 2013. http://digitalcommons.fiu.edu/etd/963.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Anxiety disorders; such as separation anxiety disorder, generalized anxiety disorder, social phobia and specific phobia, are widespread in children and adolescents. Cognitive behavioral therapy (CBT) has been shown to be effective in reducing excessive fears and anxieties in children and adolescents. Research has produced equivocal findings that involving parents in treatment of child anxiety enhances effects over individual CBT (ICBT). The present dissertation study examined whether parental involvement can enhance individual treatment effect if the parent conditions are streamlined by targeting specific parental variables. The first parent condition, Parent Reinforcement Skills Training (RFST), involved increasing mothers’ use of positive reinforcement and decreasing use of negative reinforcement. The second parent condition, Parent Relationship Skill Training (RLST), involved increasing maternal child acceptance and decreasing maternal control (or increasing autonomy granting). Results of the present dissertation findings support the use of all three treatment conditions (ICBT, RLST, RFST) for child anxiety; that is, significant reductions in anxiety were found in each of the three treatment conditions. No significant differences were found between treatment conditions with respect to diagnostic recovery rate, clinician rating, and parent rating of child anxiety. Significant differences between conditions were found on child self rating of anxiety, with some evidence to support the superiority of RLST and RFST to ICBT. These findings support the efficacy of individual, as well as parent involved CBT, and provide mixed evidence with respect to the superiority of parent involved CBT over ICBT. The conceptual, empirical, and clinical implications of the findings are discussed.
7

McCabe, Kym M. "The Effects of Yoga on Symptoms Associated with Conduct Disorder with Callous Unemotional Traits as a Moderator." Scholarly Repository, 2009. http://scholarlyrepository.miami.edu/oa_dissertations/327.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The purpose of this research was to investigate the additive therapeutic effects of a yoga intervention on the anxiety, depression and behavioral problems of conduct-disordered male adolescents in residential treatment. In addition, the moderating effects of callous-unemotional (CU) traits on outcome measures were assessed. The program consisted of a four-week intervention program in which participants were randomly assigned to either the yoga group (n=25), in which they practiced yoga with an instructor, or the control group (n=19), in which they met for a supervised study hall. The study included pre-testing on symptoms of anxiety, depression and CU traits, and post-testing on anxiety and depression measures only. Behavioral data were unavailable due to unanticipated program changes. A repeated measures MANOVA was utilized to investigate the benefits of yoga practice on a combined mental health variable that consisted of two dependent variables, anxiety and depression. A significant effect for time, but not for the interaction between time and group, was found. This indicated that both groups' scores decreased over time on the depression and anxiety variables, but that there was no statistically significant difference between the treatment groups' depression and anxiety scores over time. In spite of non-significant results, additional exploratory analysis was conducted. Results indicated a trend towards significantly greater decreases in anxiety outcomes for the yoga group vs. the control group over time. The moderating effects of CU traits on the relationships among the treatment conditions and anxiety outcomes were found to be non-significant. Limitations of the present research, including low sample size and statistical power, are discussed.
8

Obasaju, Mayowa. "Can I Talk to You? Sociopolitical Factors and their Relation to Symptoms and Treatments of Social Anxiety in a Sample of African Americans with Social Anxiety." unrestricted, 2009. http://etd.gsu.edu/theses/available/etd-06182009-101014/.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Thesis (Ph. D.)--Georgia State University, 2009.
Title from file title page. Page Anderson, committee chair; Julia Perilla, Roderick Watts, Leslie Jackson, committee members. Description based on contents viewed Sept. 14, 2009. Includes bibliographical references (p. 73-83).
9

Culberson, Alex M. "Reduction of pain after initial archwire placement: a randomized clinical trial comparing conventional and alternative treatments." The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1553782953241005.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Whittles, Randy L. "The Effects of Biopsychosocial Explanations of Social Anxiety Disorder on Stigma, Prognostic Pessimism, and Perceptions of Mental Health Treatments." OpenSIUC, 2016. https://opensiuc.lib.siu.edu/dissertations/1262.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Previous research had focused solely on examining the negative effects of biological conceptualizations of psychopathology within the context of depression (Lebowitz et al., 2013). Thus, it remained unknown as to the effects of for anxiety disorders such as Social Anxiety Disorder (SAD). The current study attempted to expand the literature by examining the effects both biological and biopsychosocial etiological explanations of SAD on ratings of stigma, prognostic pessimism, and perceptions of treatment effectiveness. 252 participants were randomized to receive either a brief psychoeducational video describing a biological explanation of SAD, a brief psycho-educational video containing a biopsychosocial explanation of SAD, or a control video intended to induce neutral affect. In contrast to initial hypotheses, results indicated no significant differences between groups in stigma, prognostic pessimism, or treatment effectiveness ratings. Similarly, a series of moderation analyses yielded no significant interactions between hypothesized moderators (e.g., previous treatment history) and respective conditions on ratings of prognostic pessimism, stigma, or treatment effectiveness. Clinical and theoretical implications, strengths and limitations, as well as future directions for research are discussed.

Книги з теми "Anxiety treatments":

1

D, DiTomasso Robert, and Gosch Elizabeth A, eds. Comparative treatments for anxiety disorders. New York: Springer Pub., 2002.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

1943-, Mavissakalian Matig, and Prien Robert F, eds. Long-term treatments of anxiety disorders. Washington, DC: American Psychiatric Press, 1996.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Camfield, David, Erica McIntyre, and Jerome Sarris, eds. Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-42307-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Rosqvist, Johan. Exposure treatments for anxiety disorders: A practitioner's guide to concepts, methods, and evidence-based practice. New York: Routledge, 2005.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

1928-, Klerman Gerald L., World Psychiatric Association. Presidential Educational Program Task Force., and World Psychiatric Association. Task Force on Panic Anxiety and Its Treatments., eds. Panic anxiety and its treatments: Report of the World Psychiatric Association Presidential Educational Program Task Force. Washington, D.C: American Psychiatric Press, 1993.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Taylor, C. Barr. The nature and treatment of anxiety disorders. New York: Free Press, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Iver, Hand, Wittchen Hans-Ulrich, Angenendt J, and European Association of Behaviour Therapy. Congress, eds. Panic and phobias: Empirical evidence of theoretical models and longterm effects of behavioral treatments. Berlin: Springer-Verlag, 1986.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Rosqvist, Johan. Exposure Treatments for Anxiety Disorders. Routledge, 2012. http://dx.doi.org/10.4324/9780203843833.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Walker, John R., Norah Vincent, and Patricia Furer. Self-Help Treatments for Anxiety Disorders. Oxford University Press, 2008. http://dx.doi.org/10.1093/oxfordhb/9780195307030.013.0037.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Poole, Hilary W. Symptoms and Treatments of Anxiety Disorders. Mason Crest, 2017.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "Anxiety treatments":

1

Marks, Isaac. "Exposure-Based Treatments for Anxiety Disorders." In Anxiety Disorders, 137–47. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5254-9_8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Montgomery, Stuart A. "Pharmacological treatments." In Handbook of Generalised Anxiety Disorder, 25–44. Tarporley: Springer Healthcare Ltd., 2009. http://dx.doi.org/10.1007/978-1-908517-02-9_7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Borkovec, T. D., and Lizabeth Roemer. "Generalized Anxiety Disorder." In Handbook of Prescriptive Treatments for Adults, 261–81. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4899-1456-9_13.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Fraser, J. Scott, and Andrew D. Solovey. "Anxiety." In Second-order change in psychotherapy: The golden thread that unifies effective treatments., 113–36. Washington: American Psychological Association, 2007. http://dx.doi.org/10.1037/11499-006.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Mendelson, Scott D. "Non-Pharmacological Treatments of Anxiety." In Herbal Treatment of Anxiety, 7–10. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003300281-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Curran, H. V. "Antianxiety Treatments and Human Memory." In New Concepts in Anxiety, 395–405. London: Macmillan Education UK, 1991. http://dx.doi.org/10.1007/978-1-349-11847-2_31.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Leigh, Bronwyn, and Robyn Brunton. "Current psychological and psychosocial treatments for anxiety during pregnancy." In Pregnancy-Related Anxiety, 123–39. London: Routledge, 2021. http://dx.doi.org/10.4324/9781003014003-12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Hedman, Erik, Brjánn Ljótsson, and Nils Lindefors. "ICBT for Severe Health Anxiety." In Guided Internet-Based Treatments in Psychiatry, 163–73. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-06083-5_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Maiello, Marco, Meredith J. Ward, and Eric Bui. "Mind–Body Treatments for Anxiety Disorders." In Clinical Handbook of Anxiety Disorders, 269–82. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30687-8_14.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Azab, Marwa. "Evidence-Based Treatments for Anxiety Disorders." In An Update on Anxiety Disorders, 189–222. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-19362-0_5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Anxiety treatments":

1

Hasanah, Umilatul, and Niken Refanthira. "Human Problems: Competitive Anxiety in Sport Performer and Various Treatments to Reduce It." In Proceedings of the 5th ASEAN Conference on Psychology, Counselling, and Humanities (ACPCH 2019). Paris, France: Atlantis Press, 2020. http://dx.doi.org/10.2991/assehr.k.200120.031.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Soares, Samantha Lia Ziotti Bohn Gonçalves, Letícia Santana Ferreira Gonçalves, Emily Thauara de Souza, Pollyana Yuri Salles Suguinoshita, Luana Isla Rocha Alves, Anna Mariah R. ibeiro Oliveira, Thalia Castro Souza, and Bárbara Machado Garcia. "Clinical correlation between Migraine and Generalized Anxiety Disorders: a literature review." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.154.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background: Migraine and anxiety are common neuro-psychiatric disorders in clinical practice, sharing symptoms and epidemiological factors among themselves. The presence of both pathologies in the same individual is frequently reported in the literature. Objectives: To report the clinical and epidemiological correlations established between generalized anxiety disorder and migraine. Methodology: Systematic review of studies published between 2016 and 2021, exploring the association between generalized anxiety disorders and Migraine. The descriptors “association”, “Migraines” and “Generalized Anxiety Disorder” were used in the LILACS, SCIELO and PUBMED databases. Fourteen articles were selected, mostly dealing with epidemiological studies. Results: Evidence suggests that these pathologies are associated and share common symptoms, pathophysiology and epidemiological factors. Studies corroborate that anxiety and painful sensation are more strongly associated with migraine than with other psychiatric illnesses. It has also demonstrated some characteristics of patients who are predisposed to develop both comorbidities such as smoke, low income and a history of other previous diseases. Common triggering factors such as pain, sleep disorders and stress can also contribute to the association between pathologies. Conclusions: Based on the studies analyzed in full, the high prevalence of both diseases in the same individual highlights the importance of research on the cause and consequence relationship between Anxiety and Migraine, since this is not yet clarified in the medical literature. In addition, paying attention to migraine correlation to generalized anxiety disorder increases the quality of life of the patient in the short and long term, as well as help in the choice of better treatments.
3

Serrano Soliva, Miriam, and Conrado Enrique Carrascosa López. "Live music, the new, safer and more effective pill on the market. A case study with hemodialysis patients in a hospital." In 3rd International Conference. Business Meets Technology. Valencia: Editorial Universitat Politècnica de València, 2021. http://dx.doi.org/10.4995/bmt2021.2021.13688.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Abstract People are more vulnerable to presenting anxiety, depression, nervousness, unfavorable quality of life, when they face situations that can threaten their life. Among these situations we find the disease, medical treatments and surgical interventions as the main ones on the list. When people get sick they endure very big and sudden changes in their lives, income, aggressive treatments, endure physical pain, these changes usually generate an unfavorable mood situation to face the disease, and in most cases worsen the previous clinical situation . Throughout history there has always been an awareness of the positive effects that music produces on people and society. Music is applied in education, in the expression of emotions, and also in the healing of patients and in many other situations. We can say that music and medicine are two closely related disciplines, with music being increasingly used as an adjuvant in different pathologies. The objective of our study was to verify the effect of classical music heard live on patients, in this case kidney patients undergoing hemodialysis (HD), who have listened to live music while receiving treatment at the Manises hospital.
4

Galbusera, Barbara. "Person with Schizophrenia and Negative Symptoms in COVID-19 Era: A New Evolution for Treatments and Economy." In 8th International Scientific Conference ERAZ - Knowledge Based Sustainable Development. Association of Economists and Managers of the Balkans, Belgrade, Serbia, 2022. http://dx.doi.org/10.31410/eraz.2022.325.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
In the last two years, the COVID-19 pandemic has become part of people’s lives, including those diagnosed with schizophrenia. Many have also exacerbated negative symptoms of the disease such as anxiety, in­creased hallucinations, and depressive symptoms. To overcome the illness, the wishes of the patients were investigated. Subsequently, starting from the personalism philosophy point of view, for a little group of the Day Care Service, a program (that has integrated pedagogical interventions, educa­tional groups, psycho-educational interventions, social skills training and telephone support) has been created to decrease the negative symptoms of schizophrenia and improve the psychophysical well-being of each patient. This research shows that it is possible to introduce a clinical-pedagogy per­spective for the care of schizophrenia patients and to mitigate the negative symptoms of schizophrenia.
5

Farias, Flávio M. de, Eyre Montevecchi, José Raphael Bokehi, Rosimere F. Santana, and Débora Christina Muchaluat-Saade. "An Immersive Memory Game as a Cognitive Exercise for Elderly Users." In Life Improvement in Quality by Ubiquitous Experiences Workshop. Brazilian Computing Society, 2022. http://dx.doi.org/10.5753/lique.2022.19997.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
In the healthcare field, games and gamification have been applied as tools to support traditional treatments for dementia, anxiety, and depression. Immersive environments using Virtual Reality (VR) can help elderly users be more focused on the tasks to be done, enhancing their memory skills. This paper proposes a new cognitive exercise called Memo-VR, which combines VR technology with interaction techniques, such as scanning and virtualizing the user’s hands, to play a memory game. Memo-VR was evaluated with a group of elderly users who gave positive feedback about the game.
6

Corpuz, Abigail. "Adverse Childhood Experiences and complex PTSD: A Theoretical Model Exploring Psychedelic Drugs as a Therapeutic Treatment." In 7th International Conference on Spirituality and Psychology. Tomorrow People Organization, 2022. http://dx.doi.org/10.52987/icsp.2022.001.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Abstract Complex posttraumatic stress disorder (cPTSD) has several detrimental consequences, including severe anxiety, emotional detachment, mood irregularities, and vivid flashbacks to trauma. In many cases, cPTSD can be linked back to adverse childhood experiences (ACEs). Treatments for cPTSD that involve psychedelic drugs are potentially beneficial, but unfortunately they are understudied in psychology labs due to their classification as a Schedule I substance. Thus, theoretical work is needed to explain potential mechanisms involved in treatment programs. In this new theoretical model, I clarify the mechanistic links between ACEs and cPTSD and then examine why psychedelic drugs may be an ideal therapeutic tool for the treatment of cPTSD. Toxic stress theory posits that exposure to extreme, frequent, and persistent ACEs without the presence of a supportive caretaker chronically activates the stress response system (Jones et al., 2021). Toxic stress results in dysregulation of the limbic-hypothalamic-pituitary-adrenal (LHPA) axis, elevating levels of catecholamines, cortisol, and proinflammatory cytokines (Thermo Fisher Scientific, n.d.). The toxic stress induced by ACEs causes cPTSD due to the persistent exposure to multiple adverse events leading to re-experience of the traumatic events, avoidance behaviors, and paranoia. Psychedelic drugs unlock repressed memories, engaging positively with negative self-concept and dysregulated emotions, which are both characteristic of the Disturbances of Self-Organization symptom cluster of cPTSD. Presentation of this theoretical model would allow for public recognition of the potential benefits of this treatment and further exploration into this topic. Keywords: PTSD, psychedelics, adverse childhood experiences, stress
7

"PS-121 - PREGNANCY AND DUAL DIAGNOSIS: IS THERE ANYTHING NEW?" In 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.ps121.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
1. Objectives: To assess the impact of the pregnancy on dual-diagnosed women. 2. Material and methods: Non-systematic review of the literature, through research on PubMed database with the keywords “dual diagnosis”, “pregnancy” and “mental illness”. 3. Results and conclusions: Dual diagnosis refers to the co-occurrence of a mental illness and substance abuse. The mean age of diagnosis for both mental illnesses and substance abuse on women is between 25 and 34 years old, which coincides with the period when women are most likely to be pregnant. One of the existent barriers on this topic is the lack of knowledge on the part of care providers as to the difficulties and treatment needs of the dual diagnosis client, with resultant anxiety and confusion about how to intervene, the efficacy of treatments, and especially how to balance the needs of the mother and fetus. The studies on this area show that patients with a substance abuse disorder or dual diagnosis had a high-risk pregnancy and less prenatal care than those with a mental illness alone, being schizophrenia the most frequent psychiatric diagnosis. For women who are dually diagnosed, the risks inherent in each disorder are combined with the potential for greater negative impact on pregnancy and the newborn.The risks of poor prenatal care, obstetric complications, and psychosocial difficulties increase and each disorder may exacerbate the other. Early identification and treatment of psychiatric disorders in pregnancy can prevent morbidity in pregnancy and postpartum with the concomitant risks to mother and baby.
8

"EPIDEMIOLOGICAL CHARACTERISTICS OF A SAMPLE OF PATIENTS WITH SUBSTANCE USE FROM THE PSYCHIATRIC CARE UNIT OF THE SOCIAL AFFAIRS SERVICE OF THE UNIVERSITY OF SALAMANCA." In 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021p019v.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Introduction: University life presents changes and challenges that may affect the mental health of its community and be the onset of substance use. Aim: To study epidemiological characteristics in our sample to help to improve prevention and treatment for mental health problems related to substance use. Materials and Methods: The descriptive study is based on a sample of 49 people, 37 women and 12 men, members of the university community. A database was designed with clinical information about psychiatric patients obtained from the interview and entry sheets during the first visit. Results: 53,1% of the sample confirmed substance use. The mean age of patients was 22,35 years and 69,2% of them were women and 30,8% were men. Alcohol was the main used substance (80,8%), followed by tobacco (57,7%) and cannabis (30,8%). Most patients were from other provinces of Spain different from Salamanca (57,7%). Law and Social Sciences (38,5%) and Health Sciences (26,9%) were the most frequent academic fields. The main contact method was self-consultation (76,9%) and in most cases (46,2%) the reason of the consultation was not specific. After the interview, the main diagnosis impressions were major depressive disorder (19,2%), anxiety disorder (15,3%) and prodromal symptoms of psychosis (15,4%). Most of the patients were treated with a combination of medication and psychotherapy (42,3%). Conclusion: We should consider the possible impact of substance use in our patient’s mental health and take account of it when choosing their treatment. We should continue studying epidemiological characteristics to help to improve prevention measures and treatments in the future.
9

De Fatima Possobon, Rosana, and Camila Beatriz Carlini Fornari. "Evaluate anxiety of adolescents during dental treatment and association with maternal anxiety." In XXIII Congresso de Iniciação Científica da Unicamp. Campinas - SP, Brazil: Galoá, 2015. http://dx.doi.org/10.19146/pibic-2015-37103.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Pereira, Naiany, Vitor Marques, Rafael Moraes, Rafael Alves, Fabíola Mamede, Weder Silva, Wanderson Santos, and Carlos Vieira. "EFFECTS OF CHEMOTHERAPY TREATMENT ON ANXIETY AND FATIGUE OF WOMEN WITH BREAST CANCER." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2074.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Breast cancer is among the main types of cancer in the world. One of the treatment alternatives is chemotherapy, which in turn can cause antagonistic effects related to behavior, reflecting anxiety, and fatigue. Objective: The aim of this study was to evaluate the effects of chemotherapy treatment on anxiety and fatigue in women with breast cancer. Methods: A total of 37 women participated in the study and were distributed into two groups, namely, 19 undergoing chemotherapy for breast cancer (52±13.11 years) and 18 apparently healthy (55.8±8.37 years). All volunteers answered questions from the questionnaire related to the Piper Fatigue Scale, composed of 22 items subdivided into 4 distinct subjective dimensions, namely, affective, sensory, cognitive, and behavioral. Anxiety was assessed using the IDATE anxiety scale, an instrument that consists of two separate self-report scales: state of anxiety and trace state, each has 20 statements in which the subjects must describe how they feel. The significance level was set a priori at p0.05). Behavior fatigue (p=0.08, ES=0.56), affective fatigue (p=0.18, ES=0.44), sensory fatigue (p=0.09, ES=0.55), cognitive fatigue (p=0.34, ES=0.31), general fatigue (p=0.09, ES=0.56), anxiety state (p=0.08, ES=0.56), and anxiety trait (p=0.92, ES=0.03). Conclusion: The results of this study show that chemotherapy treatment between the third and fourth cycles does not directly affect anxiety and fatigue in women with breast cancer.

Звіти організацій з теми "Anxiety treatments":

1

Cerón, Lissette, Mishelle Pacheco, Bolivar Delgado, and Wilson Bravo. Therapies for bruxism in dentistry: A systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0080.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: The aim of this study is to evaluate the methodological quality of the literature and the risk of bias used in systematic reviews of therapies for bruxism in dentistry, applying the Amstar II qualitative guide and to answer the following question: What do we know so far about the different treatments applied for bruxism and their effectiveness, as well as what is the overall confidence of the systematic reviews evaluating this topic? Condition being studied: There is an ongoing debate about the causal factors associated with patients diagnosed with bruxism and thus various treatment approaches, so according to the available scientific evidence there is no consensus on which is the most effective. (4) (8) (10). According to several studies, occlusal splints do not currently have a scientifically proven efficacy for the management of bruxism, because they lack randomized controlled clinical studies, and should therefore be considered as a limited treatment modality, since the effect of the splints does not seem to address the cause of bruxism and serves mainly for the management of the signs and symptoms of this disorder (11) (12). Alternative therapies such as relaxation and biofeedback have been proposed for bruxism, especially in cases of daytime bruxism, which are more related to stress and anxiety. (13). There are also studies that support the use of the NTI-tssa device can be used successfully, however, it may present side effects if necessary checks and readjustments are not performed (14). Some medications can be used to decrease bruxing episodes, but some pharmacological treatments may not be safe if used for prolonged periods of time, considering the inherent side effects or risks of dependence (15).
2

MOSKALENKO, O., and R. YASKEVICH. FACTORS AFFECTING THE FREQUENCY AND PREVALENCE OF ANXIETY DISORDERS. Science and Innovation Center Publishing House, 2022. http://dx.doi.org/10.12731/2658-4034-2022-13-1-3-95-103.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
A review of the literature on the actual problem of medicine - factors affecting the prevalence and frequency of anxiety disorders presented. The study of the factors influencing the formation and prevalence of anxiety disorders will help to increase the level of diagnosis of affective disorders and organize measures for the effective prevention and treatment of these conditions in the general medical network.
3

O'Donnell, Christopher P. Sleep Resilience, Comorbid Anxiety, and Treatment in a Muring Model of PTSD. Fort Belvoir, VA: Defense Technical Information Center, December 2012. http://dx.doi.org/10.21236/ada580131.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

O'Donnell, Christopher P. Sleep Resilience, Comorbid Anxiety, and Treatment in a Murine Model of PTSD. Fort Belvoir, VA: Defense Technical Information Center, April 2014. http://dx.doi.org/10.21236/ada603152.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Yu, Wenyan, Xuhao Li, Yunliang Zhang, and Jiguo Yang. Effecacy and Safty of Moxibustion for Depression and Anxiety in COVID-19: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0162.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: The research aims to observe the effecacy and safty of moxibustion for anxiety and depression in COVID-19. Condition being studied: Coronavirus disease 2019 (COVID-19) is an acute respiratory infectious disease that makes breathing difficult and is often accompanied by anxiety and depression. Moxibustion, a special external treatment of traditional Chinese medicine, has shown beneficial effects in the treatment of anxiety and depression. Information sources: The Cochrane Central of Controlled Trials (CENTRAL), PubMed, Embase, Chinese Biomedical Literature Database, CNKI, Weipu Chinese Science and Technology Journal Database, Wanfang Database, and related journals.
6

Wills, Jack. Effects of stress management instruction and anxiety monitoring in adult day treatment population. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.5582.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Zeng, Cong, Jianqin Cao, Xiaoyan Yang, and Ci Li. Electrophysiological indicators predict treatment response in anxiety:a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2020. http://dx.doi.org/10.37766/inplasy2020.5.0040.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Marmar, Charles R. Preventing PTSD: A Randomized Controlled Trial of Brief Anxiety Reduction Treatment for Acute Trauma (ARTAT). Fort Belvoir, VA: Defense Technical Information Center, July 2010. http://dx.doi.org/10.21236/ada637025.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Liu, Zhen, Zhizhen Lv, Jiao Shi, Shuangwei Hong, Huazhi Huang, and Lijiang Lv. Efficacy of traditional Chinese exercise in patients with chronic fatigue syndrome: a protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0022.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: Chronic fatigue syndrome (CFS) is a disease in which fatigue strikes or lasts for more than 6 months, accompanied by pain, sleep disturbance, anxiety, and depression. Moreover, it brings a heavy economic burden to society. Traditional Chinese exercises (TCEs) are a traditional Chinese medical treatment and have good efficacy on CFS, therefore, this systematic evaluation is to accurately evaluate the efficacy of TCEs on CFS. P: Patients with chronic fatigue syndrome. I: Traditional Chinese exercises. C: conventional exercise, acupuncture, physiotherapy, and other physical therapy methods. O: quality of life, fatigue, pain, sleep, anxiety, and depression. S: randomized controlled trials. Condition being studied: Chronic fatigue syndrome (CFS) is a disease in which fatigue strikes or lasts for more than 6 months, accompanied by pain, sleep disturbance, anxiety, and depression. Moreover, it brings a heavy economic burden to society. Traditional Chinese exercises (TCEs) are a traditional Chinese medical treatment and have good efficacy on CFS. Therefore, this systematic evaluation is to accurately evaluate the efficacy of TCEs on CFS, to provide an alternative therapy for clinical treatment of CFS.
10

Bogdanov, S. I. Additional professional development program "Panic Disorder and Generalized Anxiety Disorder: New in Approaches to Diagnosis and Treatment". SIB-Expertise, November 2021. http://dx.doi.org/10.12731/er0494.22112021.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
"Программа повышения квалификации «Паническое расстройство и генерализованное тревожное расстройство: новое в подходах к диагностике и лечению» составлена в соответствии с федеральным государственным образовательным стандартом по специальности 31.08.20 Психиатрия. Данная программа направлена на совершенствование имеющихся компетенций, необходимых для профессиональной деятельности, и повышения профессионального уровня в рамках имеющейся квалификации. Программа разработана в соответствии с описанием трудовых функций, входящих в профессиональный стандарт (функциональная карта вида профессиональной деятельности) «Врач-психиатр» дать слушателям теоретический и практический спектр современных знаний по диагностике и лечению панического расстройства и генерализованного тревожного расстройства в соответствие с трудовыми функциями врача-психиатра. Содержание программы построено в соответствии с модульным принципом, структурными единицами модуля являются разделы. Каждый раздел модуля подразделяется на темы, каждая тема на элементы, каждый элемент на подэлементы."

До бібліографії